Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastatic epidural cord compression.

Thomas N Byrne1

  • 1Department of Neurology, Yale University School of Medicine, 333 Cedar Street, TMP 4, PO Box 208082, New Haven, CT 06520-8082, USA. thomas.byrne@yale.edu

Current Neurology and Neuroscience Reports
|April 23, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of RPA Phosphorylation in the ATR-Dependent G2 Cell Cycle Checkpoint.

Genes·2023
Same author

Case Records of the Massachusetts General Hospital. Case 31-2016. A 53-Year-Old Man with Diplopia, Polydipsia, and Polyuria.

The New England journal of medicine·2016
Same author

Case records of the Massachusetts General Hospital. Case 27-2012. A 60-year-old woman with painful muscle spasms and hyperreflexia.

The New England journal of medicine·2012
Same author

A patient with diabetes insipidus, anterior hypopituitarism and pituitary stalk thickening.

Nature reviews. Endocrinology·2010
Same author

Supportive care of brain tumor patients.

Hematology/oncology clinics of North America·2006
Same author

Metastatic epidural spinal cord compression: update on management.

Seminars in oncology·2006
Same journal

The Noradrenergic Brain in Parkinson's Disease.

Current neurology and neuroscience reports·2026
Same journal

Mapping the Silent Onset of Parkinson's Disease: Monoamine Imaging in the Era of the Race for Preclinical Intervention.

Current neurology and neuroscience reports·2026
Same journal

Functional and Structural Brain Imaging Correlates of Treatment Response in Functional Movement Disorder.

Current neurology and neuroscience reports·2026
Same journal

Astrocytopathy in Wernicke Encephalopathy and Neuromyelitis Optica Spectrum Disorder. Pathogenic Differences With Occasional Clinical and Neuroimaging Overlap. A Review.

Current neurology and neuroscience reports·2026
Same journal

When is the Radiologically Isolated Syndrome already Multiple Sclerosis According to the 2024 McDonald Criteria?

Current neurology and neuroscience reports·2026
Same journal

Assessment and Management of Post-traumatic Headache.

Current neurology and neuroscience reports·2026
See all related articles

Advances in spinal treatments improve outcomes for vertebral metastases and metastatic epidural spinal cord compression (MESCC). Developing motor weakness is a key prognostic factor for patients with MESCC.

Area of Science:

  • Neurosurgery
  • Oncology
  • Radiology

Background:

  • Vertebral metastases and metastatic epidural spinal cord compression (MESCC) present significant challenges in patient care.
  • Recent technological and procedural advancements offer new therapeutic avenues.

Purpose of the Study:

  • To review recent advances in spinal imaging, radiosurgery, and minimally invasive procedures for treating vertebral metastases.
  • To highlight improved surgical stabilization techniques.
  • To discuss the prognostic significance of motor weakness in MESCC patients.

Main Methods:

  • Review of current literature on spinal imaging, radiosurgery, and minimally invasive spinal procedures.
  • Analysis of surgical techniques including instrumentation for spinal stabilization.

Related Experiment Videos

  • Examination of prognostic factors in patients with MESCC, focusing on the onset of motor weakness.

    • Main Results:

    • Significant progress has been made in spinal imaging, radiosurgery, and minimally invasive procedures like vertebroplasty and kyphoplasty.
    • Enhanced surgical options with instrumentation improve spinal stabilization.
    • Time to motor weakness is an independent prognostic factor for outcomes in MESCC patients.

    Conclusions:

    • Modern spinal interventions offer improved treatment success for vertebral metastases and MESCC.
    • Understanding prognostic factors, such as the timing of motor weakness, is crucial for optimizing patient outcomes.